These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 19153715
21. Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions. Blednov YA, Harris RA. Int J Neuropsychopharmacol; 2008 Sep; 11(6):775-93. PubMed ID: 18377703 [Abstract] [Full Text] [Related]
22. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Walker BM, Koob GF. Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837 [Abstract] [Full Text] [Related]
24. Acamprosate and alcohol: III. Effects on alcohol discrimination in the rat. Spanagel R, Zieglgänsberger W, Hundt W. Eur J Pharmacol; 1996 Jun 03; 305(1-3):51-6. PubMed ID: 8813531 [Abstract] [Full Text] [Related]
26. Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence. Matzeu A, Terenius L, Martin-Fardon R. Alcohol Clin Exp Res; 2018 Dec 03; 42(12):2466-2478. PubMed ID: 30320880 [Abstract] [Full Text] [Related]
34. Evaluation of alcohol use disorders pharmacotherapies in a new preclinical model of binge drinking. González-Marín MC, Lebourgeois S, Jeanblanc J, Diouf M, Naassila M. Neuropharmacology; 2018 Sep 15; 140():14-24. PubMed ID: 30031019 [Abstract] [Full Text] [Related]
37. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Richardson K, Baillie A, Reid S, Morley K, Teesson M, Sannibale C, Weltman M, Haber P. Addiction; 2008 Jun 15; 103(6):953-9. PubMed ID: 18482418 [Abstract] [Full Text] [Related]
38. Acamprosate-responsive brain sites for suppression of ethanol intake and preference. Brager A, Prosser RA, Glass JD. Am J Physiol Regul Integr Comp Physiol; 2011 Oct 15; 301(4):R1032-43. PubMed ID: 21697518 [Abstract] [Full Text] [Related]
39. Specific and nonspecific effects of naltrexone on goal-directed and habitual models of alcohol seeking and drinking. Hay RA, Jennings JH, Zitzman DL, Hodge CW, Robinson DL. Alcohol Clin Exp Res; 2013 Jul 15; 37(7):1100-10. PubMed ID: 23398292 [Abstract] [Full Text] [Related]
40. The state of pharmacotherapy for the treatment of alcohol dependence. Garbutt JC. J Subst Abuse Treat; 2009 Jan 15; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]